Cargando…

Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous tumor, resulting a challenge of developing target therapeutics. Not long ago, immune checkpoint blockade regimens combine with tyrosin kinase inhibitors have evolved frontline options in metastatic RCC, which implies arriv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Zhuangyao, Yao, Haohua, Wei, Jinhuan, Feng, Zihao, Chen, Wei, Luo, Junhang, Chen, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100830/ https://www.ncbi.nlm.nih.gov/pubmed/33968649 http://dx.doi.org/10.21037/tau-20-1348

Ejemplares similares

SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients
por: Li, Pengju, et al.
Publicado: (2020)

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022)

Analyzing and validating the prognostic value and immune microenvironment of clear cell renal cell carcinoma
por: Ke, Jingwei, et al.
Publicado: (2022)

Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival
por: Fang, Yong, et al.
Publicado: (2013)

The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2
por: Chen, Zhenhua, et al.
Publicado: (2017)

External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
por: Xie, Zhiwen, et al.
Publicado: (2021)

Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma
por: Huang, Yong, et al.
Publicado: (2018)

Prognostic value of immune-related genes in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

Urethral cavernous hemangioma: a highly misdiagnosed disease (a case report of two patients and literature review)
por: Yong, Fang, et al.
Publicado: (2019)

Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Li, Hanwen, et al.
Publicado: (2021)

Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer
por: Li, Pengju, et al.
Publicado: (2021)

Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma
por: Fan, Bo, et al.
Publicado: (2019)

Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma
por: Luo, Ting, et al.
Publicado: (2018)

Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma
por: Ding, Junping, et al.
Publicado: (2022)

The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma
por: Chen, Jie, et al.
Publicado: (2023)

Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma
por: Ren, Shiqi, et al.
Publicado: (2020)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value
por: Zhou, Jiale, et al.
Publicado: (2021)

Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Chen, Shao-An, et al.
Publicado: (2023)

Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinoma
por: Chen, Minyu, et al.
Publicado: (2023)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

The expression and prognostic value of RNA binding proteins in clear cell renal cell carcinoma
por: Li, Can-Xuan, et al.
Publicado: (2020)

Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2016)

KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma
por: Pan, Ke-Hao, et al.
Publicado: (2023)

Analyzing and Validating the Prognostic Value of a TNF-Related Signature in Kidney Renal Clear Cell Carcinoma
por: Zhang, Wenhao, et al.
Publicado: (2021)

Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2017)

C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
por: Carril-Ajuria, Lucía, et al.
Publicado: (2019)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study
por: Yao, Haohua, et al.
Publicado: (2023)

Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma
por: Bai, Jianrong, et al.
Publicado: (2022)

Validation of prognostic signature and exploring the immune-related mechanisms for NR3C2 in clear cell renal cell carcinoma
por: Chen, Daoxun, et al.
Publicado: (2023)

Robot-assisted partial nephrectomy for large complex renal cancer: step-by-step segmental artery unclamping
por: Huang, Yong, et al.
Publicado: (2022)

Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma
por: Chen, Yusa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u4tn2pur8cbb3bm8os88obm9a7